ZEB1 and neoplasm: This clinical observation is reminiscent of in vivo experiments showing that both “extremely epithelial” (generated via CRISPR/Cas9 by eliminating Zeb1 expression) and “extremely mesenchymal” cells (generated by constitutive over-expression of Zeb1), either alone or in combination, had minimal tumor initiation potential as compared to hybrid E/M cells.